Cell Line
KB-V1
Organism
human
Tissue/Cell type
cervix carcinoma / epidermal carcinoma, epithelial
Genetically modified (GenTSV)
Risk group (BioStoffV)
1
Risk assessment
According to ZKBS (https://zag.bvl.bund.de/zelllinien/detail.jsf?dswid=8716&dsrid=545&id=68)
Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)
| source | freezing date | passage no. | cell count per vial | cell culture medium incl. supplements | no. of aliquots | belongs to (full name) | rack/box in N2 tank or -80°° freezer and location (room, address) | comments |
|---|---|---|---|---|---|---|---|---|
| DSMZ | 13.03.2019+I173:Q177 | px+2 | 100000 | DMEM (4.5g/l glucose), 15% FCS, 1% P/S | 14 | Katharina Achazi (Scarlett Manzke) | 03/04, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1) | |
| DSMZ | 23.09.2014 | P2 | DMEM, 15% FCS, 1µM Doxorubicin | 10 | Stefanie Wedepohl | 05/04, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1) | derived from HeLa, P-gp overexpressed =multidrug resistant | |
| DSMZ | 14.07.2017 | ? | DMEM 10% FBS 1% P/S | 7 | Stefanie Wedepohl | 05/04, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1) | derived from HeLa, P-gp overexpressed =multidrug resistant | |
| DSMZ | 2 | Katharina Achazi (Zhaoxu Tu) | 03/09, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | 5 mg/mL | ||||
| DSMZ | 23.09.2014 | P2 | DMEM, 15% FCS, 1µM Doxorubicin | 6 | Stefanie Wedepohl | 05/05, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | derived from HeLa, P-gp overexpressed =multidrug resistant | |
| ? | 19.12.2016 | 1 | Katharina Achazi (Zhaoxu Tu) | 04/01, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1) | KB-V1-F | |||
